Hypothermia-induced cardioprotection using extended ischemia and early reperfusion cooling

Zuo Hui Shao, Wei Tien Chang, Chai Chan Kim, Kim R. Wojcik, Chin Wang Hsu, Chang Qing Li, Juan Li, Travis Anderson, Yimin Qin, Lance B. Becker, Kimm J. Hamann, Terry L. Vanden Hoeke

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Optimal timing of therapeutic hypothermia for cardiac ischemia is unknown. Our prior work suggests that ischemia with rapid reperfusion (I/R) in cardiomyocytes can be more damaging than prolonged ischemia alone. Also, these cardiomyocytes demonstrate protein kinase C (PKC) activation and nitric oxide (NO) signaling that confer protection against I/R injury. Thus we hypothesized that hypothermia will protect most using extended ischemia and early reperfusion cooling and is mediated via PKC and NO synthase (NOS). Chick cardiomyocytes were exposed to an established model of 1-h ischemia/3-h reperfusion, and the same field of initially contracting cells was monitored for viability and NO generation. Normothermic I/R resulted in 49.7 ± 3.4% cell death. Hypothermia induction to 25°C was most protective (14.3 ± 0.6% death, P <0.001 vs. I/R control) when instituted during extended ischemia and early reperfusion, compared with induction after reperfusion (22.4 ± 2.9% death). Protection was completely lost if onset of cooling was delayed by 15 min of reperfusion (45.0 ± 8.2% death). Extended ischemia/early reperfusion cooling was associated with increased and sustained NO generation at reperfusion and decreased caspase-3 activation. The NOS inhibitor N ω-nitro-L-arginine methyl ester (200 ±M) reversed these changes and abrogated hypothermia protection. In addition, the PKCε inhibitor myr-PKCε v1-2 (5 μM) also reversed NO production and hypothermia protection. In conclusion, therapeutic hypothermia initiated during extended ischemia/early reperfusion optimally protects cardiomyocytes from I/R injury. Such protection appears to be mediated by increased NO generation via activation of protein kinase Cε; nitric oxide synthase.

Original languageEnglish
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume292
Issue number4
DOIs
Publication statusPublished - Apr 2007
Externally publishedYes

Fingerprint

Induced Hypothermia
Reperfusion
Ischemia
Protein Kinase C
Nitric Oxide
Hypothermia
Cardiac Myocytes
Nitric Oxide Synthase
Protein C Inhibitor
Wounds and Injuries
Protein Kinase Inhibitors
Caspase 3
Cell Death

Keywords

  • Apoptosis
  • Nitric oxide
  • Nitric oxide synthase
  • Protein kinase Cε
  • Reperfusion injury

ASJC Scopus subject areas

  • Physiology

Cite this

Hypothermia-induced cardioprotection using extended ischemia and early reperfusion cooling. / Shao, Zuo Hui; Chang, Wei Tien; Kim, Chai Chan; Wojcik, Kim R.; Hsu, Chin Wang; Li, Chang Qing; Li, Juan; Anderson, Travis; Qin, Yimin; Becker, Lance B.; Hamann, Kimm J.; Vanden Hoeke, Terry L.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 292, No. 4, 04.2007.

Research output: Contribution to journalArticle

Shao, ZH, Chang, WT, Kim, CC, Wojcik, KR, Hsu, CW, Li, CQ, Li, J, Anderson, T, Qin, Y, Becker, LB, Hamann, KJ & Vanden Hoeke, TL 2007, 'Hypothermia-induced cardioprotection using extended ischemia and early reperfusion cooling', American Journal of Physiology - Heart and Circulatory Physiology, vol. 292, no. 4. https://doi.org/10.1152/ajpheart.01312.2005
Shao, Zuo Hui ; Chang, Wei Tien ; Kim, Chai Chan ; Wojcik, Kim R. ; Hsu, Chin Wang ; Li, Chang Qing ; Li, Juan ; Anderson, Travis ; Qin, Yimin ; Becker, Lance B. ; Hamann, Kimm J. ; Vanden Hoeke, Terry L. / Hypothermia-induced cardioprotection using extended ischemia and early reperfusion cooling. In: American Journal of Physiology - Heart and Circulatory Physiology. 2007 ; Vol. 292, No. 4.
@article{344a509688f046d98b19816cda105a9a,
title = "Hypothermia-induced cardioprotection using extended ischemia and early reperfusion cooling",
abstract = "Optimal timing of therapeutic hypothermia for cardiac ischemia is unknown. Our prior work suggests that ischemia with rapid reperfusion (I/R) in cardiomyocytes can be more damaging than prolonged ischemia alone. Also, these cardiomyocytes demonstrate protein kinase C (PKC) activation and nitric oxide (NO) signaling that confer protection against I/R injury. Thus we hypothesized that hypothermia will protect most using extended ischemia and early reperfusion cooling and is mediated via PKC and NO synthase (NOS). Chick cardiomyocytes were exposed to an established model of 1-h ischemia/3-h reperfusion, and the same field of initially contracting cells was monitored for viability and NO generation. Normothermic I/R resulted in 49.7 ± 3.4{\%} cell death. Hypothermia induction to 25°C was most protective (14.3 ± 0.6{\%} death, P <0.001 vs. I/R control) when instituted during extended ischemia and early reperfusion, compared with induction after reperfusion (22.4 ± 2.9{\%} death). Protection was completely lost if onset of cooling was delayed by 15 min of reperfusion (45.0 ± 8.2{\%} death). Extended ischemia/early reperfusion cooling was associated with increased and sustained NO generation at reperfusion and decreased caspase-3 activation. The NOS inhibitor N ω-nitro-L-arginine methyl ester (200 ±M) reversed these changes and abrogated hypothermia protection. In addition, the PKCε inhibitor myr-PKCε v1-2 (5 μM) also reversed NO production and hypothermia protection. In conclusion, therapeutic hypothermia initiated during extended ischemia/early reperfusion optimally protects cardiomyocytes from I/R injury. Such protection appears to be mediated by increased NO generation via activation of protein kinase Cε; nitric oxide synthase.",
keywords = "Apoptosis, Nitric oxide, Nitric oxide synthase, Protein kinase Cε, Reperfusion injury",
author = "Shao, {Zuo Hui} and Chang, {Wei Tien} and Kim, {Chai Chan} and Wojcik, {Kim R.} and Hsu, {Chin Wang} and Li, {Chang Qing} and Juan Li and Travis Anderson and Yimin Qin and Becker, {Lance B.} and Hamann, {Kimm J.} and {Vanden Hoeke}, {Terry L.}",
year = "2007",
month = "4",
doi = "10.1152/ajpheart.01312.2005",
language = "English",
volume = "292",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - Hypothermia-induced cardioprotection using extended ischemia and early reperfusion cooling

AU - Shao, Zuo Hui

AU - Chang, Wei Tien

AU - Kim, Chai Chan

AU - Wojcik, Kim R.

AU - Hsu, Chin Wang

AU - Li, Chang Qing

AU - Li, Juan

AU - Anderson, Travis

AU - Qin, Yimin

AU - Becker, Lance B.

AU - Hamann, Kimm J.

AU - Vanden Hoeke, Terry L.

PY - 2007/4

Y1 - 2007/4

N2 - Optimal timing of therapeutic hypothermia for cardiac ischemia is unknown. Our prior work suggests that ischemia with rapid reperfusion (I/R) in cardiomyocytes can be more damaging than prolonged ischemia alone. Also, these cardiomyocytes demonstrate protein kinase C (PKC) activation and nitric oxide (NO) signaling that confer protection against I/R injury. Thus we hypothesized that hypothermia will protect most using extended ischemia and early reperfusion cooling and is mediated via PKC and NO synthase (NOS). Chick cardiomyocytes were exposed to an established model of 1-h ischemia/3-h reperfusion, and the same field of initially contracting cells was monitored for viability and NO generation. Normothermic I/R resulted in 49.7 ± 3.4% cell death. Hypothermia induction to 25°C was most protective (14.3 ± 0.6% death, P <0.001 vs. I/R control) when instituted during extended ischemia and early reperfusion, compared with induction after reperfusion (22.4 ± 2.9% death). Protection was completely lost if onset of cooling was delayed by 15 min of reperfusion (45.0 ± 8.2% death). Extended ischemia/early reperfusion cooling was associated with increased and sustained NO generation at reperfusion and decreased caspase-3 activation. The NOS inhibitor N ω-nitro-L-arginine methyl ester (200 ±M) reversed these changes and abrogated hypothermia protection. In addition, the PKCε inhibitor myr-PKCε v1-2 (5 μM) also reversed NO production and hypothermia protection. In conclusion, therapeutic hypothermia initiated during extended ischemia/early reperfusion optimally protects cardiomyocytes from I/R injury. Such protection appears to be mediated by increased NO generation via activation of protein kinase Cε; nitric oxide synthase.

AB - Optimal timing of therapeutic hypothermia for cardiac ischemia is unknown. Our prior work suggests that ischemia with rapid reperfusion (I/R) in cardiomyocytes can be more damaging than prolonged ischemia alone. Also, these cardiomyocytes demonstrate protein kinase C (PKC) activation and nitric oxide (NO) signaling that confer protection against I/R injury. Thus we hypothesized that hypothermia will protect most using extended ischemia and early reperfusion cooling and is mediated via PKC and NO synthase (NOS). Chick cardiomyocytes were exposed to an established model of 1-h ischemia/3-h reperfusion, and the same field of initially contracting cells was monitored for viability and NO generation. Normothermic I/R resulted in 49.7 ± 3.4% cell death. Hypothermia induction to 25°C was most protective (14.3 ± 0.6% death, P <0.001 vs. I/R control) when instituted during extended ischemia and early reperfusion, compared with induction after reperfusion (22.4 ± 2.9% death). Protection was completely lost if onset of cooling was delayed by 15 min of reperfusion (45.0 ± 8.2% death). Extended ischemia/early reperfusion cooling was associated with increased and sustained NO generation at reperfusion and decreased caspase-3 activation. The NOS inhibitor N ω-nitro-L-arginine methyl ester (200 ±M) reversed these changes and abrogated hypothermia protection. In addition, the PKCε inhibitor myr-PKCε v1-2 (5 μM) also reversed NO production and hypothermia protection. In conclusion, therapeutic hypothermia initiated during extended ischemia/early reperfusion optimally protects cardiomyocytes from I/R injury. Such protection appears to be mediated by increased NO generation via activation of protein kinase Cε; nitric oxide synthase.

KW - Apoptosis

KW - Nitric oxide

KW - Nitric oxide synthase

KW - Protein kinase Cε

KW - Reperfusion injury

UR - http://www.scopus.com/inward/record.url?scp=34147099426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147099426&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.01312.2005

DO - 10.1152/ajpheart.01312.2005

M3 - Article

C2 - 17172266

AN - SCOPUS:34147099426

VL - 292

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 4

ER -